|
PDSS1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.168800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.742000E-02 |
| Normal-vs-Stage2 |
4.880600E-01 |
| Normal-vs-Stage3 |
7.985800E-01 |
| Normal-vs-Stage4 |
2.689800E-01 |
| Stage1-vs-Stage2 |
5.836600E-01 |
| Stage1-vs-Stage3 |
7.421700E-02 |
| Stage1-vs-Stage4 |
6.359100E-03 |
| Stage2-vs-Stage3 |
5.960400E-01 |
| Stage2-vs-Stage4 |
1.278590E-01 |
| Stage3-vs-Stage4 |
1.633650E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.292200E-01 |
| Normal-vs-AfricanAmerican |
1.095980E-02 |
| Normal-vs-Asian |
4.189600E-01 |
| Caucasian-vs-AfricanAmerican |
6.058800E-03 |
| Caucasian-vs-Asian |
6.111000E-01 |
| AfricanAmerican-vs-Asian |
6.738800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.196300E-02 |
| Normal-vs-Female |
4.667600E-01 |
| Male-vs-Female |
4.555500E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.776600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.165800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.895800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.847000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.835200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.147600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.715200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.617800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.092200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.624400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.355600E-03 |
| Normal-vs-Grade 2 |
4.263800E-01 |
| Normal-vs-Grade 3 |
4.975600E-01 |
| Normal-vs-Grade 4 |
8.584400E-01 |
| Grade 1-vs-Grade 2 |
1.411660E-02 |
| Grade 1-vs-Grade 3 |
1.116390E-02 |
| Grade 1-vs-Grade 4 |
4.643200E-03 |
| Grade 2-vs-Grade 3 |
8.557200E-01 |
| Grade 2-vs-Grade 4 |
3.172600E-01 |
| Grade 3-vs-Grade 4 |
3.774400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.320600E-01 |
| Normal-vs-ccB subtype |
6.316300E-02 |
| ccA subtype-vs-ccB subtype |
6.558300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.809810E-01 |
| Normal-vs-N1 |
8.586000E-02 |
| N0-vs-N1 |
4.157700E-02 |
|
|
